BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN)
CUSIP: 09061G101
Q3 2013 13F Holders as of 30 Sep 2013
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 192,632,743
- Total 13F shares
- 3,187,525
- Share change
- -500,857
- Total reported value
- $230,105,655
- Price per share
- $72.21
- Number of holders
- 13
- Value change
- -$36,130,561
- Number of buys
- 3
- Number of sells
- 6
Quarterly Holders Quick Answers
What is CUSIP 09061G101?
CUSIP 09061G101 identifies BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09061G101:
Top shareholders of BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
1.3%
|
2,473,890
|
$137,896,000 | — | 30 Jun 2013 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.46%
|
886,990
|
$49,485,000 | — | 30 Jun 2013 | |
| Retirement Systems of Alabama |
13F
|
Company |
0.05%
|
97,037
|
$5,414,000 | — | 30 Jun 2013 | |
| Zurcher Kantonalbank (Zurich Cantonalbank) |
13F
|
Company |
0.04%
|
85,365
|
$4,762,000 | — | 30 Jun 2013 | |
| PDT Partners, LLC |
13F
|
Company |
0.03%
|
60,230
|
$3,360,000 | — | 30 Jun 2013 | |
| Asset Management One Co., Ltd. |
13F
|
Company |
0.02%
|
32,004
|
$1,814,000 | — | 30 Jun 2013 | |
| Veritable, L.P. |
13F
|
Company |
0.01%
|
11,135
|
$621,000 | — | 30 Jun 2013 | |
| HARTFORD INVESTMENT MANAGEMENT CO |
13F
|
Company |
0%
|
9,150
|
$510,000 | — | 30 Jun 2013 | |
| MUFG Americas Holdings Corp |
13F
|
Company |
0%
|
4,000
|
$223,000 | — | 30 Jun 2013 | |
| E. Ohman J:or Asset Management AB |
13F
|
Company |
0%
|
3,300
|
$184,107 | — | 30 Jun 2013 | |
| HUNTINGTON NATIONAL BANK |
13F
|
Company |
0%
|
277
|
$15,000 | — | 30 Jun 2013 | |
| EMORY UNIVERSITY |
13F
|
Company |
0%
|
100
|
$6,000 | — | 30 Jun 2013 |
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) as of Q3 2013
As of 30 Sep 2013,
BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,187,525 shares.
The largest 10 holders included
WELLS FARGO & COMPANY/MN, Citadel Advisors LLC, Retirement Systems of Alabama, PDT Partners, LLC, Zurcher Kantonalbank (Zurich Cantonalbank), BANK OF MONTREAL /CAN/, DIAM Co., Ltd., HARTFORD INVESTMENT MANAGEMENT CO, AZZAD ASSET MANAGEMENT INC /ADV, and Veritable, L.P..
This page lists
13
institutional shareholders reporting positions in this security
for the Q3 2013 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2013 vs Q2 2013 Across Filers
Q2 2013 holders
12
Q3 2013 holders
13
Holder diff
1
| Investor | Q2 2013 Shares | Q3 2013 Shares | Share Diff | Share Chg % | Q2 2013 Value $ | Q3 2013 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.